250 related articles for article (PubMed ID: 21233845)
1. MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.
Afanasyeva EA; Mestdagh P; Kumps C; Vandesompele J; Ehemann V; Theissen J; Fischer M; Zapatka M; Brors B; Savelyeva L; Sagulenko V; Speleman F; Schwab M; Westermann F
Cell Death Differ; 2011 Jun; 18(6):974-84. PubMed ID: 21233845
[TBL] [Abstract][Full Text] [Related]
2. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.
Zhao Z; Ma X; Sung D; Li M; Kosti A; Lin G; Chen Y; Pertsemlidis A; Hsiao TH; Du L
RNA Biol; 2015; 12(5):538-54. PubMed ID: 25760387
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21.
Zhang Q; Miao S; Han X; Li C; Zhang M; Cui K; Xiong T; Chen Z; Wang C; Xu H
Cell Death Dis; 2018 Sep; 9(10):960. PubMed ID: 30237499
[TBL] [Abstract][Full Text] [Related]
4. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
[TBL] [Abstract][Full Text] [Related]
5. Novel miR-5582-5p functions as a tumor suppressor by inducing apoptosis and cell cycle arrest in cancer cells through direct targeting of GAB1, SHC1, and CDK2.
An HJ; Kwak SY; Yoo JO; Kim JS; Bae IH; Park MJ; Cho MY; Kim J; Han YH
Biochim Biophys Acta; 2016 Oct; 1862(10):1926-37. PubMed ID: 27475256
[TBL] [Abstract][Full Text] [Related]
6. Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma.
Rihani A; Van Goethem A; Ongenaert M; De Brouwer S; Volders PJ; Agarwal S; De Preter K; Mestdagh P; Shohet J; Speleman F; Vandesompele J; Van Maerken T
Sci Rep; 2015 Mar; 5():9027. PubMed ID: 25762502
[TBL] [Abstract][Full Text] [Related]
7. Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2.
Yan D; Dong XD; Chen X; Yao S; Wang L; Wang J; Wang C; Hu DN; Qu J; Tu L
PLoS One; 2012; 7(7):e40967. PubMed ID: 22848417
[TBL] [Abstract][Full Text] [Related]
8. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling.
Zhang C; Liu J; Wang X; Wu R; Lin M; Laddha SV; Yang Q; Chan CS; Feng Z
Oncotarget; 2014 Oct; 5(19):9106-17. PubMed ID: 25193859
[TBL] [Abstract][Full Text] [Related]
10. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
[TBL] [Abstract][Full Text] [Related]
11. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
[TBL] [Abstract][Full Text] [Related]
12. p53 and microRNA-34 are suppressors of canonical Wnt signaling.
Kim NH; Kim HS; Kim NG; Lee I; Choi HS; Li XY; Kang SE; Cha SY; Ryu JK; Na JM; Park C; Kim K; Lee S; Gumbiner BM; Yook JI; Weiss SJ
Sci Signal; 2011 Nov; 4(197):ra71. PubMed ID: 22045851
[TBL] [Abstract][Full Text] [Related]
13. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
[TBL] [Abstract][Full Text] [Related]
14. miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5.
Yang ZG; Ma XD; He ZH; Guo YX
Int Braz J Urol; 2017; 43(6):1060-1067. PubMed ID: 28727371
[TBL] [Abstract][Full Text] [Related]
15. MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma.
Wang D; Wang H; Li Y; Li Q
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29871972
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA miR-491-5p targeting both TP53 and Bcl-XL induces cell apoptosis in SW1990 pancreatic cancer cells through mitochondria mediated pathway.
Guo R; Wang Y; Shi WY; Liu B; Hou SQ; Liu L
Molecules; 2012 Dec; 17(12):14733-47. PubMed ID: 23519249
[TBL] [Abstract][Full Text] [Related]
17. MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.
Mishra PJ; Song B; Mishra PJ; Wang Y; Humeniuk R; Banerjee D; Merlino G; Ju J; Bertino JR
PLoS One; 2009 Dec; 4(12):e8445. PubMed ID: 20041160
[TBL] [Abstract][Full Text] [Related]
18. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
19. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
[TBL] [Abstract][Full Text] [Related]
20. FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.
Wang Y; Qiu C; Lu N; Liu Z; Jin C; Sun C; Bu H; Yu H; Dongol S; Kong B
Int J Oncol; 2018 Jun; 52(6):2130-2142. PubMed ID: 29620165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
